IQV
Stock Details
IQV is IQVIA Holdings Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 222.03$. Average daily volumn in 3 months 1.12M. Market cap 42.12B
Stock symbol : IQV. Exchange : NYSE. Currency : USD Lastest price : 220.50$. Total volume : 1.60M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
IQVIA Holdings Inc. (IQV)
Last Price
220.50$Change
12.77Volume
1.60M
| Previous Close | 201.74 |
| Open | 204.50 |
| Day Range | 208.59-220.73 |
| Bid | 208.24 x 800 |
| Ask | 228.33 x 900 |
| Volume | 1.6M |
| Average Volume | 1.12M |
| Market Cap | 42.12B |
| Beta | 1.46 |
| 52 Week Range | 195.57-285.61 |
| Trailing P/E | 56.12 |
| Foward P/E | 21.72 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life scienc... es and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Market Cap:
42.12BRevenue:
13.87BTotal Assets:
24.69BTotal Cash:
1.37B
News about "IQVIA Holdings Inc."
IQVIA Holdings Inc. (NYSE:IQV) Given Average Rating of “Buy” by Analysts
Source from : Defense World - 1 days ago
IQVIA Holdings Inc. (NYSE:IQV – Get Rating) has earned an average recommendation of “Buy” from the nineteen ratings firms that are covering the firm, Marketbeat reports. Three analysts have rated the ...See details»
IQVIA Holdings Inc. (NYSE:IQV) Receives Consensus Recommendation of “Buy” from Analysts
Source from : Defense World - 1 days ago
IQVIA Holdings Inc. (NYSE:IQV – Get Rating) has been given an average recommendation of “Buy” by the nineteen research firms that are presently covering the stock, Marketbeat Ratings reports. Three ...See details»
IQVIA Holdings Inc - Stock Dividends IQV
Source from : Morningstar%2c Inc. - 4 days ago
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»
Here’s Why Baron Funds Sold its IQVIA Position
Source from : Yahoo Finance - 10 days ago
In its Q1 2022 investor letter, Baron Durable Advantage Fund mentioned IQVIA Holdings Inc. (NYSE:IQV) and explained its insights for the company. Founded in 1982, IQVIA Holdings Inc. (NYSE ...See details»
IQVIA Holdings Inc.'s (IQV) CEO Ari Bousbib on Q1 2022 Results - Earnings Call Transcript
Source from : Seeking Alpha - 1 month ago
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA First Quarter 2022 Earnings Conference Call. All lines have been placed on mute to ...See details»
IQVIA (IQV) Strong on IT Infrastructure Despite Debt Woes
Source from : Yahoo Finance - 14 days ago
IQVIA Holdings Inc. IQV is currently benefiting from a strong healthcare-specific global IT infrastructure and analytics-driven clinical development capabilities. IQV recently reported solid first ...See details»
IQVIA Holdings Inc. Q1 Profit Increases, beats estimates
Source from : Business Insider - 1 month ago
(RTTNews) - IQVIA Holdings Inc. (IQV) revealed a profit for its first quarter that increased from the same period last year and beat the Street estimates. The company's bottom line came in at $325 ...See details»
IQVIA A Smart Choice In A High-Inflation Environment
Source from : Seeking Alpha - 29 days ago
IQVIA Holdings Inc. (NYSE:IQV) is a leading global contract research organization which was formed in 2016, from the merger between IMS Health Holdings, Inc. and Quintiles Transnational Holdings ...See details»
CNBC's Final Trades: Iqvia Holdings, AutoZone, Occidental Petroleum And These Undervalued Picks
Source from : Benzinga.com - 12 days ago
On CNBC’s “Halftime Report Final Trades,” Shannon Saccocia of Boston Private chose Iqvia Holdings Inc IQV, saying that the firm provides data analytics for life-sciences companies.See details»
IQVIA delivers a ‘strong first quarter,’ tops Street expectations
Source from : WRAL TechWire - 1 month ago
DURHAM – IQVIA Holdings Inc. (IQV) on Wednesday reported first-quarter net income of $325 million. The Durham, North Carolina-based company said it had profit of $1.68 per share. Earnings ...See details»
IQVIA Updates 2022 Revenue Guidance
Source from : Business Insider - 1 month ago
(RTTNews) - While reporting first-quarter results on Wednesday, IQVIA Holdings Inc. (IQV) updated its 2022 revenue guidance range. The company now expects revenue to be between $14.45 billion and ...See details»
IQVIA (NYSE:IQV) Cut to Hold at StockNews.com
Source from : ETF Daily News - 10 days ago
Johnson Financial Group Inc. bought a new stake in IQVIA in the 4th quarter worth $34,000. Finally, Quent Capital LLC grew its holdings in IQVIA by 271.8% in the 1st quarter. Quent Capital LLC now ...See details»
IQVIA (NYSE:IQV) Now Covered by Analysts at Guggenheim
Source from : ETF Daily News - 4 days ago
Vanguard Group Inc. raised its holdings in IQVIA by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 21,228,202 shares of the medical research company’s stock worth $4,908,173,000 after ...See details»
Implied RWL Analyst Target Price: $91
Source from : Nasdaq - 5 days ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, ...See details»